Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
NLRC5 encodes a member of the caspase recruitment domain-containing NLR family.
Showing 10 out of 19 products:
The NLRC5 transcript in pigs is relatively conservative among mammals and may play a vital role in immune reaction, which provides a basis for further studies on the NLRC5 function in the pig immune system and the role in comparative immunity.
Genetic polymorphisms in NLRC5 may be used as prognostic markers of survival of colorectal cancer patients, as well as for survival in response to 5-FU treatment.
knockdown of NLRC5 attenuates renal ischemia/reperfusion injury in vitro through the activation of PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies) signaling pathway.
NLRC5 may act as a key mediator in renal fibroblast activation and fibrogenesis
obtained 18 pair-wise interactions within and between the NLRC5 ad PD-L1 (show CD274 Antibodies) genes and 6 more when IFNGR (show IFNGR1 Antibodies) variants were added
Our study, for the first time, identified the possible involvement of a polymorphism within NLRC5 gene as a possible biomarker for periodontitis condition susceptibility among Italian individuals from genetic isolates.
NLRC5 interacts with miR (show MLXIP Antibodies)-34a.NLRC5 role in HPV16 persistence.
These results demonstrate that NLRC5 promotes hepatocellular carcinoma progression via the AKT (show AKT1 Antibodies)/VEGF-A (show VEGFA Antibodies) signaling pathway
NLRC5 not only positively correlates with the increase of beta-catenin (show CTNNB1 Antibodies) but also coordinates the activation of downstream Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling pathway, regulating cell proliferation, migration and invasion in hepatocellular carcinoma.
silencing NLRC5 reduced extracellular matrix expression in keloid fibroblasts through inhibiting the TGF-beta1 (show TGFB1 Antibodies)/Smad (show SMAD1 Antibodies) signaling pathway.
CITA/NLRC5 and CIITA are transcriptional regulators that orchestrate the concerted expression of critical components in the MHC class I and class II pathways, respectively. [review]
Taken together, NLRC5 promotes inflammation and fibrosis during diabetic nephropathy progression partly through the effects on NF-kappaB (show NFKB1 Antibodies) and TGF-beta (show TGFB1 Antibodies)/Smad (show SMAD1 Antibodies) pathways.
NLRC5 knockout mice fed with high fat showed accelerated fibrosis and inflammation response by promoting alpha-SMA (show SMN1 Antibodies), Collagen I, Collagen III, TLR4 (show TLR4 Antibodies)/MyD88 (show MYD88 Antibodies), phosphorylated IKKalpha (show CHUK Antibodies), IkappaBalpha (show NFKBIA Antibodies) and NF-kappaB (show NFKB1 Antibodies) expression.
NLRC5 knockout in mice exhibited greater hepatic injury after hepatic ischemia/reperfusion (I/R) injury.
The observed increases in viral titers in NLRC5-deficient mice correlated with impaired effector CD8 (show CD8A Antibodies)(+) T cell responses. Although NLRC5-deficient mice were defective at clearing the virus, they did not show an increase in morbidity or mortality following influenza virus infection because of other compensatory immune mechanisms.
NLRC5 regulates TGFB1 (show TGFB1 Antibodies)-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
NLRC5 is differentially expressed in hepatic tissues and hepatic stellate cells during hepatic fibrosis and its reversal
NLRC5 expression in T cells is required to protect them from NK-cell-mediated elimination upon inflammation.
NLRC5 and CIITA (show CIITA Antibodies) thus emerge as paradigms for a novel class of transcriptional regulators dedicated for transactivating extremely few, phylogenetically related genes.
Unusual structural features revealed by the solution NMR structure of the NLRC5 caspase (show CASP3 Antibodies) recruitment domain.
Data conclude that Nlrc5 is important in the regulation of MHC-I expression by reducing H3K27me3 on MHC-I promoter and joins CIITA as an NLR subfamily that controls MHC gene transcription.
This gene encodes a member of the caspase recruitment domain-containing NLR family. This gene plays a role in cytokine response and antiviral immunity through its inhibition of NF-kappa-B activation and negative regulation of type I interferon signaling pathways.
NLR family, CARD domain containing 5
, protein NLRC5
, NOD-like receptor C5
, caterpiller protein 16.1
, nucleotide-binding oligomerization domain protein 4
, nucleotide-binding oligomerization domain, leucine rich repeat and CARD domain containing 5
, nucleotide-binding oligomerization domains 27